BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27136898)

  • 1. 2,3,7,8 Tetrachlorodibenzo-p-dioxin-induced RNA abundance changes identify Ackr3, Col18a1, Cyb5a and Glud1 as candidate mediators of toxicity.
    Watson JD; Prokopec SD; Smith AB; Okey AB; Pohjanvirta R; Boutros PC
    Arch Toxicol; 2017 Jan; 91(1):325-338. PubMed ID: 27136898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCDD dysregulation of 13 AHR-target genes in rat liver.
    Watson JD; Prokopec SD; Smith AB; Okey AB; Pohjanvirta R; Boutros PC
    Toxicol Appl Pharmacol; 2014 Feb; 274(3):445-54. PubMed ID: 24355419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Yao CQ; Prokopec SD; Watson JD; Pang R; P'ng C; Chong LC; Harding NJ; Pohjanvirta R; Okey AB; Boutros PC
    Toxicol Appl Pharmacol; 2012 Apr; 260(2):135-45. PubMed ID: 22342509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of dioxin-altered mRNA expression in livers of dioxin-sensitive versus dioxin-resistant rats.
    Franc MA; Moffat ID; Boutros PC; Tuomisto JT; Tuomisto J; Pohjanvirta R; Okey AB
    Arch Toxicol; 2008 Nov; 82(11):809-30. PubMed ID: 18465118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity.
    Boutros PC; Yao CQ; Watson JD; Wu AH; Moffat ID; Prokopec SD; Smith AB; Okey AB; Pohjanvirta R
    Toxicol Appl Pharmacol; 2011 Mar; 251(2):119-29. PubMed ID: 21215274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats.
    Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT
    Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative toxicoproteogenomics of mouse and rat liver identifies TCDD-resistance genes.
    Prokopec SD; Lu A; Lee SCS; Yao CQ; Sun RX; Watson JD; Soliymani R; de Borja R; Wong A; Sam M; Zuzarte P; McPherson JD; Okey AB; Pohjanvirta R; Boutros PC
    Arch Toxicol; 2019 Oct; 93(10):2961-2978. PubMed ID: 31511937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver.
    Sato S; Shirakawa H; Tomita S; Ohsaki Y; Haketa K; Tooi O; Santo N; Tohkin M; Furukawa Y; Gonzalez FJ; Komai M
    Toxicol Appl Pharmacol; 2008 May; 229(1):10-9. PubMed ID: 18295293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effect on aryl hydrocarbon receptor expression in a dioxin-resistance model.
    Franc MA; Pohjanvirta R; Tuomisto J; Okey AB
    Toxicol Appl Pharmacol; 2001 Aug; 175(1):43-53. PubMed ID: 11509025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain.
    Korkalainen M; Tuomisto J; Pohjanvirta R
    Biochem Biophys Res Commun; 2004 Feb; 315(1):123-31. PubMed ID: 15013435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains.
    Pohjanvirta R; Viluksela M; Tuomisto JT; Unkila M; Karasinska J; Franc MA; Holowenko M; Giannone JV; Harper PA; Tuomisto J; Okey AB
    Toxicol Appl Pharmacol; 1999 Feb; 155(1):82-95. PubMed ID: 10036221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional profiling of rat hypothalamus response to 2,3,7,8-tetrachlorodibenzo-ρ-dioxin.
    Houlahan KE; Prokopec SD; Moffat ID; Lindén J; Lensu S; Okey AB; Pohjanvirta R; Boutros PC
    Toxicology; 2015 Feb; 328():93-101. PubMed ID: 25529477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.
    Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J
    Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCDD-induced expression of Ah receptor responsive genes in the pituitary and brain of cellular retinol-binding protein (CRBP-I) knockout mice.
    Huang P; Ceccatelli S; Hoegberg P; Sten Shi TJ; Håkansson H; Rannug A
    Toxicol Appl Pharmacol; 2003 Nov; 192(3):262-74. PubMed ID: 14575644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo up-regulation of aryl hydrocarbon receptor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in a dioxin-resistant rat model.
    Franc MA; Pohjanvirta R; Tuomisto J; Okey AB
    Biochem Pharmacol; 2001 Dec; 62(12):1565-78. PubMed ID: 11755109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships and dose responses of polychlorinated dibenzo-p-dioxins for short-term effects in 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant and -sensitive rat strains.
    Simanainen U; Tuomisto JT; Tuomisto J; Viluksela M
    Toxicol Appl Pharmacol; 2002 May; 181(1):38-47. PubMed ID: 12030841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiling of rat white adipose tissue response to 2,3,7,8-tetrachlorodibenzo-ρ-dioxin.
    Houlahan KE; Prokopec SD; Sun RX; Moffat ID; Lindén J; Lensu S; Okey AB; Pohjanvirta R; Boutros PC
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):223-31. PubMed ID: 26232522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced CYP1A1 gene expression profile in lymphocytes from mice, rats, and humans: most potent induction in humans.
    Nohara K; Ao K; Miyamoto Y; Ito T; Suzuki T; Toyoshiba H; Tohyama C
    Toxicology; 2006 Aug; 225(2-3):204-13. PubMed ID: 16839655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of arylhydrocarbon receptor variants in TCDD-induced thymic atrophy and XRE-dependent transcriptional activity in Wistar Hannover GALAS rats.
    Kawakami T; Ito T; Ohsako S; Shiizaki K; Murakami Y; Hirowatari K; Sato M; Tohyama C
    J Toxicol Sci; 2009 Apr; 34(2):209-20. PubMed ID: 19336978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
    Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.